Double-blind, Randomized, Controlled Trial of EPI-743 in Friedreich’s Ataxia. Neurodegnerative Disease Management
Kelly L. Sullivan
Part of the Epidemiology Commons
Works by Theresa A. Zesiewicz in Epidemiology
2021
2018
Comprehensive Systematic Review Summary: Treatment of Cerebellar Motor Dysfunction and Ataxia
Kelly L. Sullivan
EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results From a Phase 2A Pilot Trial
Kelly L. Sullivan
EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia
Kelly L. Sullivan
EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia
Kelly L. Sullivan
2017
Correlation of GAITRite Walkway System and Biodex Balance System Measures to the FARS Score in Friedreich's Ataxia Patients: A Validation Study
Kelly L. Sullivan
EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results From a Phase 2A Pilot Trial
Kelly L. Sullivan
Evaluation of Myocardial Structure and Function in Patients with Friedreich’s Ataxia
Kelly L. Sullivan
Longitudinal Study of Gait Dysfunction in Friedreich's Ataxia Using the GAITRite Walkway System
Kelly L. Sullivan
Relationship Between Balance Deficits and Gait Variability in Adults With Friedreich’s Ataxia
Kelly L. Sullivan
2016
Relationship between Balance Deficits and Gait Variability in Adults with Friedreich’s Ataxia
Kelly L. Sullivan
Occupational Characteristics and Patterns as Risk Factors for Parkinson’s Disease: A Case Control Study
Kelly L. Sullivan
2015
Randomized, Controlled Pilot Trial of Solifenacin Succinate for Overactive Bladder in Parkinson's Disease
Kelly L. Sullivan
Longitudinal Study of Balance Dysfunction in Friedreich’s Ataxia Using the Biodex Balance System
Kelly L. Sullivan
(x) Evaluation of Myocardial Structure and Function in Patients with Friedreich’s Ataxia
Kelly L. Sullivan
Evaluation of Myocardial Structure and Function in Patients with Friedreich’s Ataxia
Epidemiology Faculty Presentations
2014
An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease
Kelly L. Sullivan
2013
CORRECTION: Evidence-Based Guideline: Treatment of Tardive Syndromes - Report of the Guideline Development Subcommittee of the American Academy of Neurology
Kelly L. Sullivan
A New Assessment Tool for Ataxia Syndromes: The "STAND" (Scale To Assess Ataxia and Neurologic Dysfunction)
Kelly L. Sullivan
2012
2011
Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix) in the Treatment of Friedreich’s Ataxia
Kelly L. Sullivan
A Comparison of Pre- and Post-Operative Tremor Medications in Deep Brain Stimulation for Essential Tremor
Kelly L. Sullivan
A Comparison of Pre- and Post-Operative Tremor Medications in Deep Brain Stimulation for Essential Tremor
Kelly L. Sullivan
Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia
Kelly L. Sullivan
2010
2009
Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation
Kelly L. Sullivan
Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation
Kelly L. Sullivan
Treatment of Spinocerebellar Ataxia and Fragile X-Associated Tremor Ataxia Syndrome (FXTAS) with Varenicline (Chantix)
Kelly L. Sullivan
Treatment of Spinocerebellar Ataxia and Fragile X-Associated Tremor Ataxia Syndrome (FXTAS) with Varenicline (Chantix®): Results of a Retrospective, Blinded Video Analysis
Kelly L. Sullivan
2008
Delayed Thalamic Intracranial Hemorrhage in an Essential Tremor Patient Following Deep Brain Stimulation
Kelly L. Sullivan
2007
2006
A Double-Blind, Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor
Kelly L. Sullivan
2005
Levetiracetam (Keppra) in the Treatment of Choreiform Movements in Huntington's Disease
Kelly L. Sullivan
2004
A Double-Blind, Randomized Trial of Tegaserod (Zelnorm) in the Treatment of Constipation in Parkinson’s Disease
Kelly L. Sullivan
2003
Heart Failure in Parkinson’s Disease: Analysis of the United States Medicare Current Beneficiary Survey, 1997-1999
Kelly L. Sullivan